
|Videos|October 19, 2021
AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year
Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
2
Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans
3
Vitiligo is associated with mental heath conditions, other autoimmune diseases
4
Make lab monitoring of patents taking isotretinoin less routine, more based on symptoms
5
































